Showing results (231-240 of 407) with videos related to

Sort By:
Pageof 41
Rheumatology and Therapy|December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 TrialsGerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
BMC Musculoskeletal Disorders|August 1, 2015
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION studyHubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
Annals of the Rheumatic Diseases|December 14, 2012
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritisGerd R Burmester, Michael E Weinblatt, Iain B McInnes, et al.
BMC Rheumatology|December 24, 2019
Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritisFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
Rheumatology (Oxford, England)|July 8, 2022
Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1Lars Erik Kristensen, Ahmed M Soliman, Kim Papp, et al.
BMC Medical Genetics|May 14, 2020
Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groupsGunter Assmann, Michaela Köhm, Volker Schuster, et al.
Clinical Rheumatology|June 1, 2020
Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
Arthritis Care & Research|March 19, 2016
Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid ArthritisEva C Scharbatke, Frank Behrens, Marc Schmalzing, et al.
Clinical Rheumatology|March 25, 2020
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
Pageof 41